Neurogen Biomarking

Member

Neurogen Biomarking supports the early detection of Alzheimer’s disease with a seamless process that includes easy-to-use at-home testing and access to world-class neurologists, enabling more people to receive better care and achieve better outcomes. The team consists of clinical neurologists, leading scientific researchers, and healthcare entrepreneurs, united by a mission to make high-quality, early Alzheimer’s detection and care accessible to all. The team has witnessed firsthand the urgent need to improve the Alzheimer’s care journey. That’s why the team built an integrated ecosystem – bringing advanced biomarker testing, remote cognitive assessment, and expert clinical guidance directly to people concerned about their cognition. For more information, visit www.NeurogenBiomarking.com.